Literature DB >> 16823592

Responsiveness of parasite Cys His proteases to iron redox.

Thomas D Lockwood1.   

Abstract

Plasmodium falciparum growth can be opposed in erythrocyte culture or in vivo by nonselective inhibitors of CysHis proteases or pro-oxidative drugs, which elevate erythrocyte Fe(3+). However, no relationship between Fe redox and CysHis protease inhibition has been suggested. Here, mature falcipain-2 was found to be inhibited by relevant concentrations of Fe(3+) but not Fe(2+) in the presence of excess GSH or DTT. Initial inhibition of falcipain-2 by Fe(3+) (1-50 microM) was reversed in temporal correlation with the 12-14 min half-time of Fe(3+) reduction to Fe(2+) caused by GSH or DTT (6 mM). The metal-redox responses of cathepsin B from mammal, cruzain from Trypanosoma cruzi, and falcipain-2 from P. falciparum were similar. Fe(3+)/Fe(2+) speciation has features consistent with a natural redox switch modifying the reaction rate of mature CysHis proteases in virtually all cell types. Pro-oxidative antimalarial therapy might intervene in a natural mechanism normally modifying CysHis protease reaction rates via redox state of Fe pools.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823592     DOI: 10.1007/s00436-006-0239-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  34 in total

1.  Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum.

Authors:  B R Shenai; P S Sijwali; A Singh; P J Rosenthal
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

Review 2.  Microbial ferric iron reductases.

Authors:  Imke Schröder; Eric Johnson; Simon de Vries
Journal:  FEMS Microbiol Rev       Date:  2003-06       Impact factor: 16.408

3.  Mechanisms of metal-catalyzed oxidation of histidine to 2-oxo-histidine in peptides and proteins.

Authors:  C Schöneich
Journal:  J Pharm Biomed Anal       Date:  2000-01       Impact factor: 3.935

Review 4.  Hemoglobin degradation.

Authors:  D E Goldberg
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

Review 5.  Effectiveness of antimalarial drugs.

Authors:  J Kevin Baird
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

6.  Pharmacophoric features of biguanide derivatives: an electronic and structural analysis.

Authors:  Prasad V Bharatam; Dhilon S Patel; Pansy Iqbal
Journal:  J Med Chem       Date:  2005-12-01       Impact factor: 7.446

7.  Primaquine for prevention of malaria in travelers.

Authors:  J Kevin Baird; David J Fryauff; Stephen L Hoffman
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

8.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

Review 9.  Plasmodium falciparum thioredoxins and glutaredoxins as central players in redox metabolism.

Authors:  Stefan Rahlfs; Christine Nickel; Marcel Deponte; R Heiner Schirmer; Katja Becker
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

10.  Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.

Authors:  Deacon Sweeney; Michael L Raymer; Thomas D Lockwood
Journal:  Biochem Pharmacol       Date:  2003-08-15       Impact factor: 5.858

View more
  1 in total

Review 1.  Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn2+ to inhibit cysteinyl cathepsins: review and implications.

Authors:  Thomas D Lockwood
Journal:  Biometals       Date:  2019-05-01       Impact factor: 2.949

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.